Ginkgo Bioworks Holdings (DNA) Property, Plant & Equipment (Net) (2020 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Ginkgo Bioworks Holdings | 427.83 Mn | 343.30 Mn | 18.44 Mn | 157.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 157.19 Mn |
| Mar 31, 2026 | 163.02 Mn |
| Dec 31, 2025 | 167.37 Mn |
| Sep 30, 2025 | 176.58 Mn |
| Jun 30, 2025 | 186.35 Mn |
| Mar 31, 2025 | 197.83 Mn |
| Dec 31, 2024 | 203.72 Mn |
| Sep 30, 2024 | 211.04 Mn |
| Jun 30, 2024 | 210.58 Mn |
| Mar 31, 2024 | 195.99 Mn |
| Dec 31, 2023 | 188.19 Mn |
| Sep 30, 2023 | 201.60 Mn |
| Jun 30, 2023 | 294.24 Mn |
| Mar 31, 2023 | 313.97 Mn |
| Dec 31, 2022 | 314.77 Mn |
| Sep 30, 2022 | 187.58 Mn |
| Jun 30, 2022 | 176.22 Mn |
| Mar 31, 2022 | 149.17 Mn |
| Dec 31, 2021 | 145.77 Mn |
| Sep 30, 2021 | 142.70 Mn |